Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Dose Finding Trial of Prophylactic Darbepoetin Alfa to Improve Outcomes From Ischemic Complications of Surgery

NCT00647998 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT00647998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00647998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Dose Finding Trial of Prophylactic Darbepoetin Alfa to Improve Outcomes From Ischemic Complications of Surgery
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
October 31, 2010
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neuroprotection, spinal ischemia, stroke